This skill should be used when the user asks to "animate an SVG", "make a line draw itself on", "do a stroke draw-on / signature animation", "morph one shape into another", "move an element along a path", "animate an icon/logo", or "animate an SVG gradient or filter". Covers stroke-dashoffset draw-on, path morphing, motion-along-path, and animated icons/gradients/filters via CSS, SMIL, and GSAP.
日本語の概要は準備中です。原文の説明を表示しています。
iart-ai/web-animation-skills☆ 392026年6月22日 更新
PDCAサイクルでロゴを反復改善するスキル。 5つの専門エージェントが毎ラウンド議論し、SVGを生成。 ユーザーフィードバックを取り込んで何度でも改善を回す。 各ステップの議論・ロゴ・メモが全て履歴として残る。 Use when: ロゴを作りたい、アプリアイコンを作りたい、ブランドロゴをデザインしたい、 ロゴを変更したい、アイコンを作り直したい。 Triggers: "ロゴ", "logo", "アイコン作成", "アプリアイコン", "ブランドロゴ", "ロゴデザイン", "シンボルマーク", "ワードマーク", "icon design", "ロゴ作成", "ロゴ変更", "アイコン変更"
sean-sunagaku/claude-code-plugin☆ 382026年7月30日 更新
Design terminal output for a CLI tool with chalk colors, Unicode glyphs, multiple verbosity levels (human, verbose, quiet, JSON), and consistent voice rules. Covers color palette selection, status indicator design, reporter function architecture, ceremony/narrative output variants, and cross-terminal compatibility. Use when building a new CLI reporter module, adding warm narrative output to an existing tool, standardizing output across multiple commands, or designing machine-readable JSON alongside human-readable text.
日本語の概要は準備中です。原文の説明を表示しています。
pjt222/agent-almanac☆ 372026年10月13日 更新
当用户要求启动、恢复或执行 AICoding 架构 Team 时使用。负责根据项目内 agents、manifest 和 templates 建立可运行的 Team。
日本語の概要は準備中です。原文の説明を表示しています。
darker2016/workbuddy-skill-groups☆ 272026年8月17日 更新
Generate draw.io editable diagrams (.drawio, .drawio.svg) from text, images, or Excel. Orchestrates 3-agent workflow (Analysis → Manifest → SVG generation) with quality gates. Use when creating architecture diagrams, flowcharts, sequence diagrams, or converting existing images to editable format. Supports Azure/AWS cloud icons. Triggers on draw.io, drawio, ダイアグラム, アーキ図, フローチャート, シーケンス図.
aktsmm/Agent-Skills☆ 262026年10月13日 更新
Section-by-section media planning and generation. Image generation (GPT Image 2 primary, built-in fallback), logo/icon generation (Ideogram v3 → favicon set), video generation (Veo 3.1), social preview images (OG 1200x630 + AI search optimization), stock photo curation (Pexels, Pixabay), critique/remix loops (max 3 rounds), asset compression pipeline, and media performance budgets.
日本語の概要は準備中です。原文の説明を表示しています。
heymegabyte/agent-skills☆ 242026年10月11日 更新
Use when a task needs the judgment of a Coroner or medicolegal death investigator — determining whether a death is reportable/jurisdictional, distinguishing cause of death from manner of death, estimating a postmortem interval from scene findings, deciding whether an autopsy or toxicology screen is warranted, or completing a death certificate under scrutiny.
日本語の概要は準備中です。原文の説明を表示しています。
wonsukchoi/domain-experts☆ 212026年10月12日 更新
Make game-ready 2D characters, creatures, props, icons and FX as master stills, sprite sheets or animation clips. Plan size, motion and finish; generate the art (image generation is the default, through generate2dmedia route_media.py - the API when a key is configured, else the local Codex or Grok CLI); approve one master still per character; then key, slice, register, scale, palette, QA and export frames for a game engine (Aseprite JSON, Godot SpriteFrames or Sprite3D). HD finish by default, pixel finish on request. Character animation is one image-to-video clip per action from the master (video2dsprite); sheets are for FX, icons and props. Use for sprites, masters, sheets, frame-by-frame animation and packaging frames from any source. Not for maps, tiles or backgrounds (generate2dmap), video clips (video2dsprite), code-drawn art (codeart2d, only on request) or calling an image or video API by itself (generate2dmedia).
日本語の概要は準備中です。原文の説明を表示しています。
gabrielmoreira/agent-skills-mirror☆ 192026年10月13日 更新
Generate ready-to-paste AI image-gen prompts for 2D game art (character/sprite, icon/UI/item, background/tileset) that stay consistent with the project's art style across separate chat sessions in Claude/Gemini/ChatGPT chat UIs. Use when the user wants to render, generate, or create game art/sprites/icons/backgrounds with AI, or mentions an "art style bible" for a game project. Maintains a persistent `art-style-bible.md` so style doesn't drift between requests, and gives a post-generation checklist plus post-processing guidance for common technical misses (transparency, size, aspect ratio).
日本語の概要は準備中です。原文の説明を表示しています。
DangQuangSE/team-development-skills☆ 192026年10月9日 更新
Design and build cohesive web pages with custom visual identity — landing pages and portfolios get rich anatomy + section archetypes; any other page type (blog, about, pricing, contact, coming-soon, dashboard, admin, e-commerce, custom) is supported through generic anatomy + skeleton. Use this skill whenever the user mentions: landing page, portfolio, personal site, hero section, marketing page, product page, sales page, splash page, blog page, about page, pricing page, contact page, coming-soon, waitlist, dashboard, admin panel, e-commerce store, redesign my site, design my portfolio, build a portfolio, work showcase, hire-me page, perfect-ui, perfect landing, or asks to create any web page surface. Two tiers: special (landing | portfolio — rich treatment) and generic (everything else — universal craft toolkit). Self-contained 8-phase pipeline: vibe discovery → visual direction (color/typography/mood) → custom icon set (NO emoji, NO icon library) → AI-generated visuals → optional shader effects layer → inline plan + implement on Next.js + Tailwind + shadcn. Always proposes effect layer as optional. No refusals; outputs distinctive sites, not AI slop.
日本語の概要は準備中です。原文の説明を表示しています。
tensology/decisionsai☆ 172026年10月13日 更新
Write, audit, or improve an iOS App Store listing — app name, subtitle, keyword field, screenshots, app icon, preview video, creative assets, tags, ratings strategy, localization, and featuring nominations. Use when creating or reviewing App Store metadata, doing keyword research, planning a metadata update, or when the user mentions ASO, App Store Optimization, app store listing, keywords, subtitle, screenshot captions, preview video, app icon, Liquid Glass, creative assets, product page header, search results creative, Asset Library, featuring, ratings prompt, or Apple Ads.
日本語の概要は準備中です。原文の説明を表示しています。
alexszczurek/before-skills☆ 172026年8月27日 更新
关于巴西中央银行法规合规的完整指引:《国民货币委员会第 4,893/2021 号决议》(网络安全政策)、《巴西中央银行第 85/2021 号决议》(GRSIC)、巴西开放金融(BCB 第 32/2020 号决议及更新)以及 BACEN 的其他审慎规则。涵盖网络安全政策的起草和审查、事件行动与响应计划(PARI)、信息和通信服务风险管理(GRSIC)、开放金融中的同意与数据共享、API 要求、第三方管理(外包)和 BACEN 制裁。触发词:Bacen、Banco Central、CMN 4.893、Resolução 4.893、segurança cibernética bancária、PARI、GRSIC、Open Finance、Open Banking、compartilhamento de dados financeiros、consentimento Open Finance、API financeira、outsourcing bancário、risco cibernético、incidente cibernético banco、LGPD financeira、fintech compliance、instituição financeira、DICT、Pix segurança。
日本語の概要は準備中です。原文の説明を表示しています。
CSlawyer1985/legal-skillhub☆ 152026年9月23日 更新
Quantifies biodiversity from species abundance/incidence tables using Hill numbers (iNEXT) with coverage-based rarefaction-extrapolation (Chao & Jost 2012), asymptotic richness via Chao1/ACE/jackknife as a lower bound, Baselga turnover/nestedness partition with the Podani alternative as sensitivity check, mandatory Hellinger transformation before ordination (Legendre & Gallagher 2001), Faith PD and SES_MPD/SES_MNTD with explicit null-model choice, and Maire 2015 functional-diversity dimensionality optimization. Use when comparing diversity across sites with unequal sampling effort, picking the right richness estimator for singleton-heavy amplicon data, partitioning beta diversity into turnover vs nestedness, reporting Hill-number effective species counts rather than raw entropies, computing SES_MPD with explicit null-model justification, or deciding whether to apply standard metrics to compositional amplicon data. Not for clinical 16S microbiome diversity (see microbiome/diversity-analysis).
日本語の概要は準備中です。原文の説明を表示しています。
lilinji/GeneTind-Life-Skills☆ 142026年8月21日 更新
This skill recommends discontinuing glucocorticoid when the response to HPA axis recovery tests (morning cortisol, ACTH stimulation, or insulin-induced hypoglycemia) is normal, indicating adequate adrenal function recovery. Use in postoperative Cushing’s syndrome patients with at least one intact adrenal gland when test results are available.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 142026年10月5日 更新
This skill recommends glucocorticoid replacement and patient education for hypocortisolemic patients after surgical remission of Cushing's syndrome. Use when a postoperative Cushing's patient exhibits low cortisol (e.g., morning cortisol <5 µg/dL) or symptoms of adrenal insufficiency.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 142026年10月5日 更新
This skill suggests administering a glucocorticoid antagonist (e.g., mifepristone) in patients with Cushing's disease who have diabetes or glucose intolerance and are not surgical candidates or have persistent disease after transsphenoidal surgery. Consider when encountering persistent hypercortisolism after TSS, contraindications to surgery, or comorbid diabetes/glucose intolerance requiring medical control.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 142026年10月5日 更新
This skill recommends regularly evaluating for corticotroph tumor progression using pituitary MRIs and ACTH levels in patients with known Cushing's disease who underwent bilateral adrenalectomy and in patients undergoing this procedure for presumed occult ectopic ACTH secretion. Triggers include postoperative follow‑up after bilateral adrenalectomy, rising ACTH levels, or new pituitary lesion on MRI suggestive of tumor progression.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 142026年10月5日 更新
Selects spironolactone as first-line mineralocorticoid receptor antagonist for bilateral primary aldosteronism, with eplerenone as an alternative when spironolactone–related adverse effects are problematic. Trigger phrases include 'confirmed bilateral PA on AVS', 'idiopathic adrenal hyperplasia', 'bilateral adrenal hyperplasia', 'glucocorticoid-remediable aldosteronism', and 'initiating medical therapy for bilateral adrenal disease'.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 142026年10月5日 更新
Recommends confirmatory testing with corticotropin stimulation test in patients presenting with clinical symptoms or signs suggesting PAI (e.g., fatigue, hypotension, hyponatremia, hyperpigmentation) when the patient's condition permits safe testing. Use when a clinician identifies suggestive features and circumstances allow outpatient stimulation testing without imminent need for emergency glucocorticoids.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 142026年10月5日 更新
Educates patients with primary adrenal insufficiency on increasing glucocorticoid dosage during intercurrent illness, fever (≥38°C), or physiological stress, including recognition of precipitating symptoms (e.g., fever, vomiting, trauma) and actions to prevent impending adrenal crisis. Trigger phrases: fever, intercurrent illness, stress, vomiting, inability to tolerate oral meds, need for parenteral glucocorticoid.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 142026年10月5日 更新
Initiates a 6‑month trial of DHEA replacement in women with primary adrenal insufficiency (PAI) who have persistent low libido, depressive symptoms, or low energy despite otherwise optimized glucocorticoid and mineralocorticoid therapy. If the patient does not report a sustained beneficial effect after 6 months, discontinue DHEA.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 142026年10月5日 更新
Calculates the lowest effective glucocorticoid dose (dexamethasone or prednisone) to normalize blood pressure and serum potassium in glucocorticoid-remediable aldosteronism (GRA/FH-I) by titrating to biochemical and clinical targets. Indicated when initiating medical treatment for confirmed GRA, triggered by findings such as early-onset hypertension, family history of stroke before age 40, spontaneous hypokalemia, or suppressed plasma renin activity with elevated aldosterone.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 142026年10月5日 更新
Suggests that pregnant patients with primary adrenal insufficiency be monitored for clinical signs of glucocorticoid over- or under-replacement such as normal weight or gain, fatigue, postural hypotension or hypertension, and hyperglycemia, with at least one review each trimester. Use when managing a pregnant patient with PAI to assess glucocorticoid dosing adequacy.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 142026年10月5日 更新
Suggests monitoring DHEA replacement in women with primary adrenal insufficiency (PAI) by measuring morning serum DHEAS levels before the daily dose, targeting the mid‑normal range. Consider when evaluating low libido, depressive symptoms, or low energy despite optimized glucocorticoid and mineralocorticoid replacement.
日本語の概要は準備中です。原文の説明を表示しています。
dromlakhani/MD2SKILL☆ 142026年10月5日 更新